PFNX Projected Dividend Yield
Pfenex Inc ( AMEX : PFNX )Pfenex is a development and licensing biotechnology company focused on utilizing its proprietary protein production platform, Pfenex Expression Technology®, to develop protein therapeutics to improve existing therapies and create therapies for diseases still waiting to be addressed. The U.S. Food and Drug Administration-approved PF708 product is indicated for the treatment of osteoporosis in certain patients at high risk for fracture. Co.'s other product includes PF743 (JZP-458), which it is developing in collaboration with Jazz Pharmaceuticals Ireland Limited for the treatment of acute lymphoblastic leukemia. Co. has added PF810, a peptide based therapeutic, to its wholly owned pipeline. 20 YEAR PERFORMANCE RESULTS |
PFNX Dividend History Detail PFNX Dividend News PFNX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |